Emily Fraser

2.5k total citations · 1 hit paper
24 papers, 527 citations indexed

About

Emily Fraser is a scholar working on Pulmonary and Respiratory Medicine, Neurology and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Emily Fraser has authored 24 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 7 papers in Neurology and 4 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Emily Fraser's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), Long-Term Effects of COVID-19 (7 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). Emily Fraser is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), Long-Term Effects of COVID-19 (7 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). Emily Fraser collaborates with scholars based in United Kingdom, United States and Germany. Emily Fraser's co-authors include Rachel K. Hoyles, Ling‐Pei Ho, Mitchell Chen, Fergus Gleeson, Anthony McIntyre, Betty Raman, James T. Grist, Guilhem Collier, Jim M. Wild and Johan De Meester and has published in prestigious journals such as Radiology, BMJ and Thorax.

In The Last Decade

Emily Fraser

18 papers receiving 511 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long COVID is associated with severe cognitive slowing: a multicentre cross-sectional study

2024 42 citations Sijia Zhao, Philipp A. Reuken et al. EClinicalMedicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emily Fraser United Kingdom	9	200	122	122	93	74	24	527
C. Corey Hardin United States	14	182 0.9×	334 2.7×	194 1.6×	98 1.1×	7 0.1×	29	909
Rachel Beekman United States	11	313 1.6×	37 0.3×	73 0.6×	17 0.2×	25 0.3×	38	577
Elizabeth M. Tunnicliffe United Kingdom	14	97 0.5×	52 0.4×	37 0.3×	49 0.5×	9 0.1×	33	1.3k
Karolina M. Zaręba United States	15	183 0.9×	62 0.5×	195 1.6×	116 1.2×	4 0.1×	40	1.2k
Xuhong Ding China	9	398 2.0×	227 1.9×	258 2.1×	39 0.4×	7 0.1×	23	674
Hendrik Suhling Germany	17	39 0.2×	440 3.6×	57 0.5×	65 0.7×	10 0.1×	66	922
Е. V. Kryukov Russia	9	70 0.3×	91 0.7×	101 0.8×	29 0.3×	20 0.3×	144	395
Rajesh R. Patel United States	12	105 0.5×	93 0.8×	182 1.5×	50 0.5×	6 0.1×	33	497
Dazhong Tang China	6	241 1.2×	41 0.3×	280 2.3×	29 0.3×	2 0.0×	18	612
Liuqun Jia China	12	62 0.3×	112 0.9×	25 0.2×	231 2.5×	6 0.1×	33	617

Countries citing papers authored by Emily Fraser

Since Specialization

Citations

This map shows the geographic impact of Emily Fraser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Fraser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Fraser more than expected).

Fields of papers citing papers by Emily Fraser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Fraser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Fraser. The network helps show where Emily Fraser may publish in the future.

Co-authorship network of co-authors of Emily Fraser

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Fraser. A scholar is included among the top collaborators of Emily Fraser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Fraser. Emily Fraser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gerichten, Johanna von, Matt Spick, Emily Fraser, et al.. (2025). Single-cell lipidomics: protocol development for reliable cellular profiling using capillary sampling. The Analyst. 150(7). 1261–1270. 4 indexed citations

Fraser, Emily, et al.. (2025). Self-report physical activity instruments for United States adults: A systematic review of initial validation studies. Preventive Medicine. 203. 108477–108477.

Kohli-Lynch, Maya, et al.. (2025). Fifteen-minute consultation: Restricted eating. Archives of Disease in Childhood Education & Practice. 110(3). 94–100.

Zhao, Sijia, Philipp A. Reuken, Stefan Brodoehl, et al.. (2024). Long COVID is associated with severe cognitive slowing: a multicentre cross-sectional study. EClinicalMedicine. 68. 102434–102434. 42 indexed citations breakdown →

Fraser, Emily, et al.. (2023). Neutrophil levels correlate with quantitative extent and progression of fibrosis in IPF: results of a single-centre cohort study. BMJ Open Respiratory Research. 10(1). e001801–e001801. 6 indexed citations

Gill, Peter, et al.. (2023). Psychosocial treatments for nightmares in adults and children: a systematic review. BMC Psychiatry. 23(1). 283–283. 8 indexed citations

Collier, Guilhem, Laura Saunders, Laurie Smith, et al.. (2023). Age, sex and lung volume dependence of 129Xe MRI gas exchange metrics. OA4952–OA4952.

Fraser, Emily, et al.. (2023). A combined measure of blood leukocytes, FVC and quantitative CT is highly predictive of mortality in idiopathic pulmonary fibrosis (IPF). PA1133–PA1133.

Fraser, Emily, Praveen Weeratunga, & Ling‐Pei Ho. (2022). Management of Sarcoidosis: When to Treat, How to Treat and for How Long?. 11(4). 151–159. 2 indexed citations

10.

Grist, James T., Guilhem Collier, Huw Walters, et al.. (2022). Lung Abnormalities Detected with Hyperpolarized ¹²⁹ Xe MRI in Patients with Long COVID. Radiology. 305(3). 709–717. 64 indexed citations

11.

Lyon, Paul, Emily Fraser, Peter Saunders, et al.. (2022). Increased monocyte level is a risk factor for radiological progression in patients with early fibrotic interstitial lung abnormality. ERJ Open Research. 8(3). 226–2022. 7 indexed citations

12.

Wright, Charlotte, et al.. (2022). Weight loss during ambulatory tube weaning: don’t put the feeds back up. Archives of Disease in Childhood. 107(8). 767–771. 2 indexed citations

13.

Tucker, Elizabeth W., et al.. (2022). Long COVID rehabilitation: A collaborative approach to managing a new phenomenon. Physiotherapy. 114. e186–e186. 1 indexed citations

14.

Grist, James T., Mitchell Chen, Guilhem Collier, et al.. (2021). Hyperpolarized ¹²⁹Xe MRI Abnormalities in Dyspneic Patients 3 Months after COVID-19 Pneumonia: Preliminary Results. Radiology. 301(1). E353–E360. 82 indexed citations

15.

Fraser, Emily. (2021). Persistent pulmonary disease after acute covid-19. BMJ. 373. n1565–n1565. 7 indexed citations

16.

Fraser, Emily. (2020). Long term respiratory complications of covid-19. BMJ. 370. m3001–m3001. 153 indexed citations

17.

Fraser, Emily, et al.. (2020). Readily accessible CT scoring method to quantify fibrosis in IPF. BMJ Open Respiratory Research. 7(1). e000584–e000584. 15 indexed citations

18.

Wham, Carol, et al.. (2017). Malnutrition risk of older people across district health board community, hospital and residential care settings in New Zealand. Australasian Journal on Ageing. 36(3). 205–211. 15 indexed citations

19.

Fraser, Emily & Rachel K. Hoyles. (2016). Therapeutic advances in idiopathic pulmonary fibrosis. Clinical Medicine. 16(1). 42–51. 19 indexed citations

20.

Tsakiris, Dimitrios, Vianda S Stel, Patrik Finne, et al.. (2009). Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study. Nephrology Dialysis Transplantation. 25(4). 1200–1206. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact